Skip to main content

Effective January 1, 2026, Commonwealth Care Alliance, Inc. (CCA) will update our preferred diabetic testing supplies: 

Important: There will be no transition period for LifeScan diabetic products. To prevent any disruption in your patients’ care, we ask that you: 

If you believe continued use of LifeScan products is medically necessary, you may submit an exception request for your patient.  

If you have any questions, please contact Tuli Mitra-Majumdar, Manager of Pharmacy Strategy, at [email protected].